Background Repeat hospitalizations, complications, and psychosocial burdens are common
in patients with left ventricular assist devices (LVAD). Specialist palliative care (sPC) …

Methods: Clinical trials relevant to care of patients with HF, LVADs, and the role of palliative
care were analyzed for this narrative review. Key Content and Findings: Palliative care …

Background: When left ventricular assist device (LVAD) therapy no longer is able to achieve
patients' desired quality of life, withdrawal of LVAD therapy (WLVAD) may be requested …

Background: Left ventricular assist devices (LVADs) are an essential part of advanced heart
failure (HF) management, either as a bridge to transplantation or destination therapy …

BACKGROUND Trial and registry data have reported mortality rates and causes of death in
patients with left ventricular assist devices (LVADs); however, a more granular description is …

Context Patients with left ventricular assist devices (LVADs) need expert palliative care at
the end of life. In the US, hospice may provide this care, but few patients enroll, and …

Background—Despite the ability of left ventricular assist device as destination therapy (DT-
LVAD) to prolong survival for many patients with advanced heart failure, little is known about …

Context Left ventricular assist devices (LVADs) are increasingly used to improve quality of
life for end-stage heart failure patients. The Joint Commission now requires preimplantation …

Background: The difference of end-of-life care for left ventricular assist device (LVAD)
patients, between destination therapy (DT) and bridge to transplant (BTT), and the effect of …

Left ventricular assist devices (LVAD) are increasingly being used to treat end-stage heart
failure. Despite the increased prevalence of these devices, there is a still a high 1-year …